Viral factors correlate with hepatitis B e antigen seroconverson in patients with chronic hepatitis B

Liver International

Volumn 26, Issue 8, 2006, Pages 949-955

  Liu, Chun Jen ^a   Chen, Pei Jer ^a   Lai, Ming Yang ^a   Lin, Feng Yi ^a   Wang, Tzusan ^a   Kao, Jia Horng ^a   Chen, Ding Shinn ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Basal core promoter; e antigen; Precore; Seroconversion; Viral load

Indexed keywords

HEPATITIS B(E) ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE EXACERBATION; FEMALE; GENOTYPE; HEPATITIS B; HUMAN; MALE; PROGNOSIS; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SEROCONVERSION; VIRUS LOAD; VIRUS MUTATION;

EID: 84984535989     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01319.x     Document Type: Article

References (34)

1. Magnius LO, Espmark JA. New specificities in Australia antigen positive sera distinct from the LeBouvier determinants. J Immunol 1972; 109: 1017-21.
2. Shikata T, Karasawa T, Abe K, et al. Hepatitis B e antigen and infectivity of hepatitis B virus. J Infect Dis 1977; 136: 571-6.
3. Milich D, Liang TJ. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 2003; 38: 1075-86.
4. Realdi G, Alberti A, Rugge M, et al. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 1980; 79: 195-9.
5. Hoofnagle JH, Dusheiko GM, Seeff LB, Jones EA, Waggoner JG, Bales ZB. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 1981; 94: 744-8.
6. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2001; 34: 1225-41.
7. Hsu YS, Chien RN, Yeh CT, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002; 35: 1522-7.
8. Liaw YF. Hepatitis flares and hepatitis B e antigen seroconversion: implications in anti-hepatitis B virus therapy. J Gastroenterol Hepatol 2003; 18: 246-52.
9. Bruss V, Gerlich WH. Formation of transmembraneous hepatitis B e-antigen by cotranslational in vitro processing of the viral precore protein. Virology 1988; 163: 268-75.
10. Garcia PD, Ou JH, Rutter WJ, Walter P. Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: After signal peptide cleavage translocation can be aborted and the product released into the cytoplasm. J Cell Biol 1988; 106: 1093-104.
11. Brunetto MR, Stemier M, Schodel F, et al. Identification of HBV variants, which cannot produce precore-derived HBeAg and may be responsible for severe hepatitis. Ital J Gastroenterol 1989; 21: 151-4.
12. Carman WF, Jacyna MR, Hadziyannis S, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; 2: 588-91.
13. Okamoto H, Yotsumoto S, Akahane Y, et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990; 64: 1298-303.
14. Li J, Buckwold VE, Hon MW, Ou JH. Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation. J Virol 1999; 73: 1239-44.
15. Buckwold VE, Xu Z, Chen M, Yen TS, Ou JH. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 1996; 70: 5845-51.
16. Lin CL, Liao LY, Wang CS, et al. Evolution of hepatitis B virus precore/ basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy. Liver Int 2004; 24: 9-15.
17. Lindh M, Gustavson C, Mardberg K, Norkrans G, Dhillon AP, Horal P. Mutation of nucleotide 1,762 in the core promoter region during hepatitis B e seroconversion and its relation to liver damage in hepatitis B e antigen carriers. J Med Virol 1998; 55: 185-90.
18. Lindh M, Hannoun C, Dhillon AP, Norkrans G, Horal P. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis 1999; 179: 775-82.
19. Maruyama T, Kuwata S, Koike K, et al. Precore wild-type DNA and immune complexes persist in chronic hepatitis B after seroconversion: No association between genome conversion and seroconversion. Hepatology 1998; 27: 245-53.
20. Yamaura T, Tanaka E, Matsumoto A, et al. A case-control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter. J Med Virol 2003; 70: 545-52.
21. Chu CM, Yeh CT, Lee CS, Sheen IS, Liaw YF. Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: Clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion. J Clin Microbiol 2002; 40: 16-21.
22. Liu CJ, Chen PJ, Lai MY, Kao JH, Chen DS. Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion. J Med Virol 2004; 74: 237-45.
23. Misawa N, Matsumoto A, Tanaka E, et al. Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics. J Med Virol 2006; 78: 68-73.
24. Liu CJ, Kao JH, Chen DS. Molecular assays for hepatitis B virus infection. Hepatology 2003; 38: 1311.
25. Lok AS, McMahon BJ. Chronic hepatitis B: Update of recommendations. Hepatology 2004; 39: 857-61.
26. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73.
27. Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men. J Natl Cancer Inst 2005; 97: 265-72.
28. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. J Med Virol 2004; 72: 363-9.
29. Yeh SH, Tsai CY, Kao JH, et al. Combined real-time PCR quantification and signature single nucleotide polymorphism genotyping of hepatitis B virus in one-tube reaction. J Hepatol 2004; 41: 659-66.
30. Liu CJ, Chen PH, Lai MS, et al. A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation. Gastroenterology 2003; 124: 80-90.
31. Chen BF, Liu CJ, Jow JM, Chen PJ, Kao JH, Chen DS Evolution of hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C. J Gen Virol 2006; 87: 39-49.
32. Liu CJ, Kao JH, Chen DS. Therapeutic implications of hepatitis B virus genotypes. Liver Int 2005; 25: 1097-107.
33. Kao J, Chen P, Lai M, Chen D. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 2000; 118: 554-9.
34. Lee CM, Chen CH, Lu SN, et al. Prevalence and clinical implications of hepatitis B virus genotypes in southern Taiwan. Scand J Gastroenterol 2003; 38: 95-101.